Date

Friday, July 7 2017

Venue

PT. Merck Sharp Dohme Pharma Tbk
Wisma BNI 46, Lantai 27
Jl. Jend. Sudirman Kav. 1
Jakarta

Time

10:00 (GMT+7)

Agenda

AGM:

1. Approval of the Annual Report of the Board of Directors related to the Company's Business Activities and the Financial Administration Procedure of the Company for the fiscal year ended December 31, 2016.

2. Ratification of Company's Balance Sheet and Income Statement for the fiscal year ended on December 31, 2016 which has been audited by Public Accounting Firm, Tanudiredja, Wibisana & Rekan.

3. The utilization of Net Income for the fiscal year ended on December 31, 2016.

4. The appointment of Public Accounting Firm that will audit the Company's Financial Statements for the fiscal year ended on December 31, 2017, taking into account of the proposals from Board of Commissioners, as well as determining the honorarium amount for Public Accounting Firm.

SCPI - PT. Organon Pharma Indonesia Tbk

Rp 0

0 (0%)